Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study

Loes H. C. Nissen*, Lauranne A. A. P. Derikx, Anouk M. E. Jacobs, Carla M. van Herpen, Wietske Kievit, Rob Verhoeven, Esther van den Broek, Elise Bekers, Tim van den Heuvel, Marieke Pierik, Janette Rahamat-Langendoen, Robert P. Takes, Willem J. G. Melchers, Iris D. Nagtegaal, Frank Hoentjen, Dutch Initiative Crohn Colitis ICC; Dutch Head Neck Soc; PALGA Grp; IBD HNC Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2015-2026
Number of pages12
JournalInflammatory Bowel Diseases
Volume24
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • inflammatory bowel diseases
  • head and neck cancer
  • pharyngeal carcinoma
  • oral cavity carcinoma
  • immunosuppressive therapy
  • EVIDENCE-BASED CONSENSUS
  • ORGAN TRANSPLANT RECIPIENTS
  • SQUAMOUS-CELL CARCINOMAS
  • HUMAN-PAPILLOMAVIRUS
  • OROPHARYNGEAL CANCER
  • CROHNS-DISEASE
  • IMMUNOSUPPRESSIVE THERAPY
  • DIAGNOSIS
  • AZATHIOPRINE
  • METAANALYSIS

Cite this